Merck Pfizer terminate Bavencio head and neck cancer trial

Merck, Pfizer terminate Bavencio head and neck cancer trial

07:51 EDT 16 Mar 2020 | PharmaTimes

The decision follows advice from the trial's independent data monitoring committee.

Original Article: Merck, Pfizer terminate Bavencio head and neck cancer trial

More From BioPortfolio on "Merck, Pfizer terminate Bavencio head and neck cancer trial"